OUR STORY

We turn complexity,
into clarity

Our mission

Giving people in biotech and pharma
solutions to navigate an optimal approval strategy

For many, regulatory strategy is risky—constantly changing approval landscapes that can lead to financial losses if not managed effectively. Reducing risk and increasing confidence requires data. That's where we come in.

Our story

RxTROSPECT was founded to enhance the performance of staff working in regulatory affairs, by giving them more confidence in understanding agency decision-making.

After years of navigating regulatory approval pathways as a GRL, our founder set out to create an intelligence platform that empowers people with fast and reliable data analytics, needed to understand what fed into agency decision-making for oncology drug approvals.

turn-key solution for regulatory professionals

8000+

Data points

25+

Years of approval data

700+

Approved indications

Our founders

Our co-founders bring together decades of experience across drug development, regulatory affairs, and technology

RxTROSPECT Co-founder - Dan Milberg
RxTROSPECT Co-founder - Mark Rutter

Mark Rutter

Co-founder

×

Mark Rutter

Co-founder

Mark was responsible for the company’s vision, purpose, and design. Mark’s tenacity, coupled with his extensive experience in drug development and regulatory strategy led to the creation of RxTROSPECT and underscores Mark’s commitment to finding solutions for an industry seeking to tackle the toughest of challenges.

Mark Rutter

Dan Milberg

Co-founder

Trusted by well
respected companies

As seen in

Our relationships

We're proud of working with our strategic
partners and industry leaders


Careers

We are a tech company — we carefully design products that have a positive impact in people’s day-to-day work performance. A career at RxTROSPECT is for men and women who care about their colleagues and show it by working together to create industry leading solutions.